Seated Outcome Measures in Children With Duchenne Muscular Dystrophy

被引:0
|
作者
Kern, Rebecca [1 ,2 ]
Carvell, Kimberly [1 ]
Gupta, Apeksha [3 ]
Verma, Sumit [1 ,4 ]
机构
[1] Childrens Healthcare Atlanta, Dept Rehabil & Neurosci, Atlanta, GA USA
[2] Pasco Cty Sch, Student Support Programs & Serv, Land O Lakes, FL USA
[3] Nicklaus Childrens Hosp, Personalized Med Initiat & Hlth Outcomes, Miami, FL USA
[4] Emory Univ, Sch Med, Dept Pediat & Neurol, Atlanta, GA USA
关键词
Duchenne muscular dystrophy; hand-held dynamometry; Pediatric Evaluation of Disability Inventory; seated reach distance; seated trunk strength; sitting balance; NATURAL-HISTORY; MUSCLE WEAKNESS; CLINICAL-TRIAL; RELIABILITY; VALIDITY; TRUNK;
D O I
10.1097/PEP.0000000000000916
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Purpose: Quantifiable motor strength measures to assess disease severity throughout the continuum of Duchenne muscular dystrophy (DMD) are needed. To study the feasibility of seated trunk strength using hand-held dynamometry (HHD) and caregiver-reported subjective functional independence measures in boys with DMD. Methods: Prospective, cross-sectional, observational study of 18 participants with DMD enrolled from pediatric muscular dystrophy clinic during routine clinical assessment. Hand-held dynamometry, seated reach distance test and Pediatric Evaluation of Disability Inventory (PEDI) were administered. Results: All study participants regardless of the walking status were able to complete the seated function tests demonstrating feasibility. The age of the participants correlated negatively with PEDI mobility and positively with HHD extension scores. The seated measures did not statistically correlate with PEDI mobility scores. Conclusions: Seated motor strength measures and PEDI mobility scores are feasible. The PEDI mobility and HHD extension scores correlate with age. Study limitations included single-center experience and cross-sectional data. Video abstract link: https://www.dropbox.com/s/s4r0k7o6s0tfbkb/PT-Seated-Measures-And-DMD-2022.mp4?dl=0
引用
收藏
页码:375 / 380
页数:6
相关论文
共 50 条
  • [1] SEATED OUTCOME MEASURES IN CHILDREN WITH DUCHENNE MUSCULAR DYSTROPHY
    Kern, Rebecca
    Verma, Sumit
    Carvell, Kimberly
    Gupta, Apeksha
    MUSCLE & NERVE, 2022, 66 : S102 - S102
  • [2] Commentary on "Seated Outcome Measures in Children With Duchenne Muscular Dystrophy"
    Kiefer, Michael
    Townsend, Elise
    PEDIATRIC PHYSICAL THERAPY, 2022, 34 (03) : 381 - 381
  • [3] Outcome Measures in Duchenne Muscular Dystrophy
    Benemei, Silvia
    Gatto, Francesca
    Boni, Luca
    Pane, Marika
    ACTA NEUROLOGICA BELGICA, 2024,
  • [4] OUTCOME MEASURES FOR DUCHENNE MUSCULAR DYSTROPHY: IMPLICATIONS FOR TRIALS
    Domingos, Joana
    Eagle, Michelle
    Moraux, Amelie
    Butler, Jordan
    Decostre, Valerie
    Ridout, Deborah
    Mayhew, Anna
    Selby, Victoria
    Guglieri, Michela
    Van der Holst, Menno
    Jansen, Merel
    Verschuuren, Jan G. M.
    de Groot, Imelda
    Niks, Erik
    Servais, Laurent
    Hogrel, Jean-Yves
    Straub, Volker
    Voit, Thomas
    Ricotti, Valeria
    Muntoni, Francesco
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 : A63 - A63
  • [5] Outcome measures validation study for mesoangioblasts transplantation in children affected by Duchenne muscular dystrophy
    Bonfiglio, S.
    Lerario, A.
    Tettamanti, A.
    Marktel, S.
    Napolitano, S.
    Previtali, S.
    Scarlato, M.
    Natali-Sora, M. G.
    Bresolin, N.
    Comi, G.
    Gatti, R.
    Ciceri, F.
    Cossu, G.
    Torrente, Y.
    NEUROMUSCULAR DISORDERS, 2010, 20 (9-10) : 668 - 669
  • [6] Functional Outcome Measures (FOMs) guiding clinical care of children with Duchenne muscular dystrophy
    Khandekar, G.
    Shyamprasad, S. Banavara
    Babu, R. Ramesh
    Kumar, A.
    Satyam, P.
    Maganthi, M.
    Krishna, G.
    Mathew, A.
    NEUROMUSCULAR DISORDERS, 2024, 43
  • [7] Outcome measures validation study for mesoangioblasts transplantation in children affected by Duchenne Muscular Dystrophy
    Bonfiglio, S.
    Lerario, A.
    Tettamanti, A.
    Marktel, S.
    Napolitano, S.
    Previtali, S.
    Scarlato, M.
    Natali-Sora, M. G.
    Bresolin, N.
    Comi, G.
    Gatti, R.
    Ciceri, F.
    Cossu, G.
    Torrente, Y.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 528 - 528
  • [8] Outcome Measures Validation Study for Mesoangioblasts Transplantation in Children Affected by Duchenne Muscular Dystrophy
    Bonfiglio, Serena
    Lerario, Alberto
    Tettamanti, Andrea
    Marktel, Sarah
    Napolitano, Sara
    Previtali, Stefano
    Scarlato, Marina
    Sora, Maria Grazia Natali
    Bresolin, Nereo
    Comi, Giancarlo
    Gatti, Roberto
    Ciceri, Fabio
    Cossu, Giulio
    Torrente, Yvan
    NEUROLOGY, 2010, 74 (09) : A218 - A219
  • [9] Therapeutic opportunities and clinical outcome measures in Duchenne muscular dystrophy
    Ricci, Giulia
    Bello, Luca
    Torri, Francesca
    Schirinzi, Erika
    Pegoraro, Elena
    Siciliano, Gabriele
    NEUROLOGICAL SCIENCES, 2022, 43 (Suppl 2) : 625 - 633
  • [10] Longitudinal reliability of outcome measures in patients with Duchenne muscular dystrophy
    Nagy, Sara
    Schadelin, Sabine
    Hafner, Patricia
    Bonati, Ulrike
    Scherrer, Delia
    Ebi, Selina
    Schmidt, Simone
    Orsini, Anna-Lena
    Bieri, Oliver
    Fischer, Dirk
    MUSCLE & NERVE, 2020, 61 (01) : 63 - 68